Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision Next revisionBoth sides next revision | ||
mrepo:topics:biologicalsamples [24/09/2018 @ 16:49] – nmpo | mrepo:topics:biologicalsamples [25/09/2018 @ 15:52] – nmpo | ||
---|---|---|---|
Line 162: | Line 162: | ||
DNA extractions were conducted on the EDTA tube used in the first round blood haematology analysis. Samples for lymphoid cell line transformations were originally collected in 1999; for those that did not previously provide a sample, one was collected in 2006-10. \\ \\ | DNA extractions were conducted on the EDTA tube used in the first round blood haematology analysis. Samples for lymphoid cell line transformations were originally collected in 1999; for those that did not previously provide a sample, one was collected in 2006-10. \\ \\ | ||
- | {{mrepo:bloods_0610.jpg? | + | |
+ | < | ||
+ | <table x:str="" | ||
+ | < | ||
+ | <tr style=" | ||
+ | <td class=" | ||
+ | < | ||
+ | </ | ||
+ | <td class=" | ||
+ | < | ||
+ | </ | ||
+ | <td class=" | ||
+ | < | ||
+ | </ | ||
+ | <td class=" | ||
+ | < | ||
+ | </ | ||
+ | </ | ||
+ | < | ||
+ | <td > | ||
+ | < | ||
+ | </ | ||
+ | <td > | ||
+ | <p>1 x 2.7ml EDTA tube (EN1)</ | ||
+ | </ | ||
+ | < | ||
+ | < | ||
+ | </ | ||
+ | <td > | ||
+ | < | ||
+ | </ | ||
+ | </ | ||
+ | |||
+ | < | ||
+ | <td > | ||
+ | < | ||
+ | </ | ||
+ | <td > | ||
+ | <p>1 x 2.7ml EDTA tube (EN2)</ | ||
+ | </ | ||
+ | < | ||
+ | <p> None as sample was sent for HbA1c and red cell folate analysis <p> | ||
+ | </ | ||
+ | <td > | ||
+ | < | ||
+ | </ | ||
+ | </ | ||
+ | |||
+ | < | ||
+ | <td > | ||
+ | < | ||
+ | </ | ||
+ | <td > | ||
+ | <p>1 x 2.7 Fluoride tube (FL N1)</ | ||
+ | </ | ||
+ | < | ||
+ | < | ||
+ | </ | ||
+ | <td > | ||
+ | < | ||
+ | </ | ||
+ | </ | ||
+ | |||
+ | < | ||
+ | <td > | ||
+ | < | ||
+ | </ | ||
+ | <td > | ||
+ | <p>1 x 7.5ml Lithium heparin tube (trace metal) (LH N1)</ | ||
+ | </ | ||
+ | < | ||
+ | <p>LH INS for insulin; LH VITC for vitamin C analysis</ | ||
+ | </ | ||
+ | <td > | ||
+ | <p>LH B1, LH C1, LH C2, LH C3 </ | ||
+ | </ | ||
+ | </ | ||
+ | |||
+ | <tr > | ||
+ | <td > | ||
+ | < | ||
+ | </ | ||
+ | <td > | ||
+ | <p>1 x 85ml CPDA (for cell lines if required) (CP N1)</ | ||
+ | </ | ||
+ | < | ||
+ | < | ||
+ | </ | ||
+ | <td > | ||
+ | < | ||
+ | </ | ||
+ | </ | ||
+ | |||
+ | <tr > | ||
+ | <td > | ||
+ | < | ||
+ | </ | ||
+ | <td > | ||
+ | <p>1 x 7.5ml Serum tube (SE N1)</ | ||
+ | </ | ||
+ | < | ||
+ | <p> Samples from the two serum tubes were used to produce priority aliquots SE A1 for TFTs and SE A2 for analyses at NHR</ | ||
+ | </ | ||
+ | <td > | ||
+ | <p>SE B1, SE C1, SE C2</ | ||
+ | </ | ||
+ | </ | ||
+ | |||
+ | <tr > | ||
+ | <td > | ||
+ | < | ||
+ | </ | ||
+ | <td > | ||
+ | <p>1 x 7.5ml Serum tube (SE N2)</ | ||
+ | </ | ||
+ | < | ||
+ | <p> Samples from the two serum tubes were used to produce priority aliquots SE A1 for TFTs and SE A2 for analyses at NHR</ | ||
+ | </ | ||
+ | <td > | ||
+ | <p>SE B1, SE C1, SE C2</ | ||
+ | </ | ||
+ | </ | ||
+ | |||
+ | <tr > | ||
+ | <td > | ||
+ | < | ||
+ | </ | ||
+ | <td > | ||
+ | <p>1 x 4.9ml EDTA tube (E N3)</ | ||
+ | </ | ||
+ | < | ||
+ | < | ||
+ | </ | ||
+ | <td > | ||
+ | <p>E B1, E C1</ | ||
+ | </ | ||
+ | </ | ||
+ | <tr > | ||
+ | <td > | ||
+ | < | ||
+ | </ | ||
+ | <td > | ||
+ | <p>1 x 10ml Citrate tube (CI N1)</ | ||
+ | </ | ||
+ | < | ||
+ | < | ||
+ | </ | ||
+ | <td > | ||
+ | <p>CI B1, CI C1, CI C2</ | ||
+ | </ | ||
+ | </ | ||
+ | |||
+ | </ | ||
+ | </ | ||
+ | </ | ||
+ | *Blood tubes/ | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
\\ \\ | \\ \\ | ||
__Urine__ | __Urine__ | ||
Line 179: | Line 340: | ||
A number of assays have been undertaken and the remaining aliquots of EDTA, citrate plasma and serum are stored at the Bristol Bioresource Laboratories. | A number of assays have been undertaken and the remaining aliquots of EDTA, citrate plasma and serum are stored at the Bristol Bioresource Laboratories. | ||
- | {{mrepo: | + | {{mrepo: |
---- | ---- | ||
\\ | \\ |